FGFR1 is a cell surface receptor overexpressed by several tumors, including breast, lung, ovarian, head and neck and bladder cancers and constitutes an attractive tumor marker for development of targeted therapeutics [44]. The gene discussed is FGFR1; the disease is urinary bladder carcinoma.